- Home
- FATE vs MAV Comparison
FATE vs MAV Comparison
Compare FATE & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- MAV
- Stock Information
- Founded
- FATE 2007
- MAV 2003
- Country
- FATE United States
- MAV United States
- Employees
- FATE N/A
- MAV N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- MAV Finance Companies
- Sector
- FATE Health Care
- MAV Finance
- Exchange
- FATE Nasdaq
- MAV Nasdaq
- Market Cap
- FATE 177.7M
- MAV 198.7M
- IPO Year
- FATE 2013
- MAV N/A
- Fundamental
- Price
- FATE $1.14
- MAV $8.28
- Analyst Decision
- FATE Hold
- MAV
- Analyst Count
- FATE 7
- MAV 0
- Target Price
- FATE $3.83
- MAV N/A
- AVG Volume (30 Days)
- FATE 1.9M
- MAV 66.2K
- Earning Date
- FATE 08-12-2025
- MAV 01-01-0001
- Dividend Yield
- FATE N/A
- MAV 4.30%
- EPS Growth
- FATE N/A
- MAV N/A
- EPS
- FATE N/A
- MAV N/A
- Revenue
- FATE $13,335,000.00
- MAV N/A
- Revenue This Year
- FATE N/A
- MAV N/A
- Revenue Next Year
- FATE N/A
- MAV N/A
- P/E Ratio
- FATE N/A
- MAV N/A
- Revenue Growth
- FATE 105.85
- MAV N/A
- 52 Week Low
- FATE $0.66
- MAV $6.37
- 52 Week High
- FATE $5.92
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- FATE 46.69
- MAV 54.37
- Support Level
- FATE $1.05
- MAV $8.29
- Resistance Level
- FATE $1.18
- MAV $8.36
- Average True Range (ATR)
- FATE 0.08
- MAV 0.05
- MACD
- FATE -0.00
- MAV 0.00
- Stochastic Oscillator
- FATE 54.76
- MAV 67.33
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax, and as a secondary objective, to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.